News Extra [these Stories Appear Only On The Web]
Haemophilia patients launch action against Bayer over contaminated blood products
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7402.1286-g (Published 12 June 2003) Cite this as: BMJ 2003;326:1286
- Deborah Josefson
- Nebraska
A class action lawsuit has been launched against the Bayer and Baxter corporations on behalf of people with haemophilia in Asia and Latin America who contracted HIV or hepatitis through contaminated blood products supplied by the companies.
Also named in the lawsuit were the Armour Pharmaceutical Company and Alpha Therapeutic Corporation. The suit was filed in a US federal court in California.
All four companies are accused of distributing …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.